Literature DB >> 18951272

The effect of chitosan molecular weight on the characteristics of spray-dried methotrexate-loaded chitosan microspheres for nasal administration.

Yu Sun1, Fude Cui, Kai Shi, Jiamiao Wang, Mengmeng Niu, Ruijing Ma.   

Abstract

In this article, the effect of the chitosan molecular weight (MW) on the characteristics of methotrexate (MTX)-encapsulated non-cross-linked chitosan microspheres was studied. Microspheres composed of low-molecular-weight (LMW, 40,000 Da), medium-molecular-weight (MMW, 480,000 Da) and high-molecular-weight (HMW, 850,000 Da) chitosan with the same degree of deacetylation (96%) were obtained by a simple spray-drying method. The MW of chitosan had a noticeable influence on the size distribution, encapsulation efficiency, micromeritic properties (angle of repose and bulk density), controlled release behavior, and mucoadhesive properties. The entrapment efficiencies were in the range of 90-99%. Spray-dried microspheres had a D(50) value of 3.3-4.9 microm, which was suitable for nasal insufflations. The microspheres with LMW chitosan have the best flowability and highest bulk density but were found to be poor in terms of adhesion and in controlling the release behavior of MTX. The MMW chitosan microspheres exhibited the strongest adhesion to the mucosal surface, and the angle of repose values were between 34 and 47 degrees. They could control the release rate by modifying the drug/polymer ratios. Microspheres with HMW chitosan exhibited a lower adhesion than MMW chitosan and a lower release rate of MTX. The physical state of MTX in the chitosan matrix was studied by differential scanning calorimetry, which indicated the presence of a solid dispersion of the amorphous drug in the chitosan matrix. Nasal ciliotoxity showed only minor cilia irritation due to the microspheres, and consequently, they are suitable for nasal drug delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18951272     DOI: 10.1080/03639040802395185

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  7 in total

1.  Novel morphologies of poly(allyamine hydrochloride)-methotrexate nanoassemblies for methotrexate delivery.

Authors:  Wei-Yuan Wang; Xiao-Han Ju; Xiu-Fen Zhao; Xiao-Dong Li; Shu-Ping Li; Fu-Gui Song
Journal:  RSC Adv       Date:  2018-02-20       Impact factor: 4.036

2.  Development of lovastatin-loaded poly(lactic acid) microspheres for sustained oral delivery: in vitro and ex vivo evaluation.

Authors:  Qigang Guan; Wei Chen; Xianming Hu
Journal:  Drug Des Devel Ther       Date:  2015-02-10       Impact factor: 4.162

3.  In Vitro Release of 5-Fluorouracil and Methotrexate from Different Thermosensitive Chitosan Hydrogel Systems.

Authors:  Ahmed M Mohammed; Shaaban K Osman; Khaled I Saleh; Ahmed M Samy
Journal:  AAPS PharmSciTech       Date:  2020-05-13       Impact factor: 3.246

Review 4.  Film forming systems for topical and transdermal drug delivery.

Authors:  Kashmira Kathe; Harsha Kathpalia
Journal:  Asian J Pharm Sci       Date:  2017-07-05       Impact factor: 6.598

5.  Production and Characterization of Chitosan-Polyanion Nanoparticles by Polyelectrolyte Complexation Assisted by High-Intensity Sonication for the Modified Release of Methotrexate.

Authors:  Yhors Ciro; John Rojas; Maria J Alhajj; Gustavo A Carabali; Constain H Salamanca
Journal:  Pharmaceuticals (Basel)       Date:  2020-01-08

6.  Development of Methotrexate Complexes Endowed with New Biological Properties Envisioned for Musculoskeletal Regeneration in Rheumatoid Arthritis Environments.

Authors:  Daniel Fernández-Villa; Rosa Ana Ramírez-Jiménez; Inmaculada Aranaz; Niuris Acosta; Blanca Vázquez-Lasa; Luis Rojo
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

7.  Design and Characterization of Spray-Dried Chitosan-Naltrexone Microspheres for Microneedle-Assisted Transdermal Delivery.

Authors:  Abayomi T Ogunjimi; Jennifer Fiegel; Nicole K Brogden
Journal:  Pharmaceutics       Date:  2020-05-29       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.